Stay updated on Taletrectinib ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Taletrectinib ROS1+ NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.5 has been added to the history, replacing the previous v3.5.4, representing an updated version of the page’s historical record.
    Difference
    0.1%
    Check dated 2026-06-05T11:14:34.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page history now includes a new revision entry labeled v3.5.4, updating the release notes metadata for this study record.
    Difference
    0.1%
    Check dated 2026-05-15T06:45:36.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The site’s interface revision label updates from v3.5.2 to v3.5.3, reflecting a ClinicalTrials.gov platform/version release. No study-related information or record content changes are indicated by this change.
    Difference
    0.1%
    Check dated 2026-04-24T06:15:58.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the history and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:51:05.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision history now includes a new entry for v3.5.0 and removes the previous v3.4.3 entry.
    Difference
    0.1%
    Check dated 2026-03-19T04:12:44.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the Record History, and the previous entry v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T23:28:37.000Z thumbnail image

Stay in the know with updates to Taletrectinib ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.